Enovis Corporation

Enovis Corporation

ENOVยทNYSE

$21.56

-1.7%
HealthcareMedical - Devices

Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.

At a Glance

Live Snapshot
Market Cap$1.24B
EPS-20.8600
P/E Ratio-1.03
Earnings Date08/06/2026
Enovis Corporation

Enovis Corporation Fair Value Envelope

ENOV ยท NYSE

Our analysis suggests that ENOV has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $21.56, this represents a potential HIDDEN relative to our calculated worth for Enovis Corporation.

Intrinsic Value
Current Price: $21.56

Owner Earnings Valuation Tool

Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation

Historical Financial Data

Base year metrics used for projections

$
%
$
%
$
$

Projection Settings

Forecast period and terminal assumptions

%
%

DCF Valuation Summary

Calculation flow from present value to intrinsic value per share

Present Value$1,616.8B
+ Cash & Equivalents$36.4M
Firm Value$1,616.8B
- Debt$1.4B
Equity Value$1,615.4B
/ Shares Outstanding57,171,768B
DCF Value$28.3K
UNDERVALUED BY 130955%

Owner Earnings Projections

Operating Cash Flow - Maintenance CapEx = Owner Earnings

Metric
Year 1
Year 2
Year 3
Year 4
Year 5
Year 6
Year 7
Year 8
Year 9
Year 10
Operating Cash Flow
$434.6M
$869.2M
$1.7B
$3.5B
$7.0B
$13.9B
$27.8B
$55.6B
$111.3B
$222.5B
Maintenance CapEx
-$79.0M
-$157.9M
-$315.8M
-$631.6M
-$1.3B
-$2.5B
-$5.1B
-$10.1B
-$20.2B
-$40.4B
Owner Earnings
$355.6M
$711.3M
$1.4B
$2.8B
$5.7B
$11.4B
$22.8B
$45.5B
$91.0B
$182.1B
Discount Factor
0.926
0.857
0.794
0.735
0.681
0.630
0.583
0.540
0.500
0.463
Present Value
$329.3M
$609.8M
$1.1B
$2.1B
$3.9B
$7.2B
$13.3B
$24.6B
$45.5B
$84.3B
Terminal Value represents 88.7% of Enterprise Value